
The factors underlying the choice of zzso for cancer patients in primary care are largely zzso Our aim was to describe cancer patients' first treatment episode with zzso in relation to disease characteristics and clinical zzso 

During 1997 and 1998, a zzso cohort of zzso incident cancer patients from a Danish county was zzso The patients were followed up from diagnosis to death or until 31 December 2003, and data on their use of zzso were obtained from a prescription zzso 

Eventually, zzso of the cancer patients became incident users of zzso zzso treatment was initiated close to the diagnosis date in zzso of the zzso Most incident users zzso were not terminal when they began using zzso and zzso survived the first treatment zzso Of those who died, zzso received zzso in their terminal zzso The zzso rates of new zzso users were zzso related to the zzso cancer survival zzso A weak zzso was the first choice in zzso of the zzso users and in zzso of the terminal zzso No statistically significant differences in zzso use were found between men and zzso 

zzso use in cancer patients was not confined to the terminal zzso Treatment with zzso should be viewed as a dynamic condition, with patients shifting between periods of use and zzso The aggressiveness of the cancer and the presence of zzso were characteristics found to be strong zzso of zzso zzso 

